Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: importance of international travel
KB Laupland, DL Church, J Vidakovich, M Mucenski… - Journal of Infection, 2008 - Elsevier
OBJECTIVES: Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli have
emerged as significant causes of community-onset disease. We sought to identify risk factors …
emerged as significant causes of community-onset disease. We sought to identify risk factors …
Prevention strategies for antimicrobial resistance: a systematic review of the literature
WP Caron, SA Mousa - Infection and Drug Resistance, 2010 - Taylor & Francis
Antibiotics offer great benefits by reducing the duration and severity of illnesses and aiding
in infection transmission control. With this being said, the inexorable process of antimicrobial …
in infection transmission control. With this being said, the inexorable process of antimicrobial …
CTX-M-15-Producing Escherichia coli Clinical Isolates in Cairo (Egypt), Including Isolates of Clonal Complex ST10 and Clones ST131, ST73, and ST405 in Both …
N Fam, V Leflon-Guibout, S Fouad… - Microbial drug …, 2011 - liebertpub.com
In Egypt, little is known about the genetic background of Escherichia coli isolates harboring
extended-spectrum β-lactamase (ESBL). Five hundred twenty Enterobacteriaceae were …
extended-spectrum β-lactamase (ESBL). Five hundred twenty Enterobacteriaceae were …
High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran
H Mehrgan, M Rahbar, Z Arab-Halvaii - The Journal of infection in …, 2010 - jidc.org
Background: Extended-spectrum beta (β)-lactamase (ESBL)-producing enterobacteria are
major emerging pathogens in nosocomial infections. Methodology: The combination disk …
major emerging pathogens in nosocomial infections. Methodology: The combination disk …
Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria
PA Gross, B Patel - Clinical infectious diseases, 2007 - academic.oup.com
Positive urinary tract culture results often represent asymptomatic bacteriuria, which does
not need to be treated with antimicrobial agents. Avoiding treatment of asymptomatic …
not need to be treated with antimicrobial agents. Avoiding treatment of asymptomatic …
Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals
S Hoşoğlu, S Gündeş, F Kolaylõ, A Karadenizli… - Indian journal of medical …, 2007 - Elsevier
Purpose: To study the prevalence of TEM-, SHV-and GES-type β-lactamases among
Escherichia coli and Klebsiella pneumoniae strains having ceftazidime MICs higher than 2 …
Escherichia coli and Klebsiella pneumoniae strains having ceftazidime MICs higher than 2 …
In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical …
A Kiremitci, EC Dinleyici, N Erben… - Expert Opinion on …, 2008 - Taylor & Francis
Objective: To evaluate the in vitro effect of ertapenem, imipenem and meropenem in clinical
isolates of extended-spectrum β-lactamase (ESBL)-producing strains of Escherichia coli and …
isolates of extended-spectrum β-lactamase (ESBL)-producing strains of Escherichia coli and …
Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study
K Demirdag, S Hosoglu - The Journal of Infection in Developing Countries, 2010 - jidc.org
Introduction: Increased production of extended-spectrum β-lactamases (ESBLs) has become
an important issue for treatment of severe Klebsiella pneumoniae (K. pneumoniae) …
an important issue for treatment of severe Klebsiella pneumoniae (K. pneumoniae) …
The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from …
B Bazzaz, M Naderinasab, A Mohamadpoor… - Acta microbiologica et …, 2009 - akjournals.com
This study was conducted at a 900+ bed general teaching hospital, from May to September
2007, in Iran. The aim of this study was to determine the prevalence of extended-spectrum …
2007, in Iran. The aim of this study was to determine the prevalence of extended-spectrum …
[PDF][PDF] HASTANE KAYNAKLI ESCHERICHIA COLI VE KLEBSIELLA SUŞLARININ ERTAPENEM VE DİĞER ANTİBİYOTİKLERE DUYARLILIĞI
ÖG TUNÇCAN, DT KETEN, M DİZBAY, K HIZEL - Ankem Derg, 2008 - researchgate.net
Hastane kaynaklı infeksiyonlardan izole edilen genişlemiş spektrumlu beta-laktamaz
(GSBL) pozitif ve negatif Escherichia coli ve Klebsiella suşlarında ertapenem duyarlığını …
(GSBL) pozitif ve negatif Escherichia coli ve Klebsiella suşlarında ertapenem duyarlığını …